human | Q5 |
P496 | ORCID iD | 0000-0001-7442-2132 |
P2038 | ResearchGate profile ID | Malcolm_Reed |
P1153 | Scopus author ID | 57202213914 |
P214 | VIAF ID | 103816708 |
P7859 | WorldCat Identities ID (superseded) | lccn-nb2010008760 |
P108 | employer | University of Sheffield | Q823917 |
P735 | given name | Malcolm | Q6584302 |
Malcolm | Q6584302 | ||
P106 | occupation | researcher | Q1650915 |
oncologist | Q16062369 | ||
P21 | sex or gender | male | Q6581097 |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q37052173 | A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients |
Q37313778 | A breast cancer risk haplotype in the caspase-8 gene |
Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
Q37534963 | A critical analysis of current in vitro and in vivo angiogenesis assays |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q44385739 | A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility |
Q48303260 | A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer |
Q37599352 | A role for XRCC2 gene polymorphisms in breast cancer risk and survival |
Q47385333 | Addressing overtreatment of screen detected DCIS; the LORIS trial |
Q92252577 | Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration Data |
Q72795362 | Advanced gastrointestinal malignancy or benign inflammatory disease? An unusual presentation of sclerosing mesenteritis. Report of a case |
Q79085503 | An audit of the management of soft tissue sarcoma within a health region in the UK |
Q49058397 | Angiogenesis induction and regression in human surgical wounds. |
Q84384562 | Angiosarcoma |
Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
Q38711330 | Assessing medical student knowledge and attitudes about shared decision making across the curriculum: protocol for an international online survey and stakeholder analysis. |
Q46247407 | Assessing the functional role of caspase-8 gene variants in breast cancer. |
Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
Q45188733 | Association of a common variant of the CASP8 gene with reduced risk of breast cancer |
Q36981021 | Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer |
Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q52003179 | Assuring the quality of high-stakes undergraduate assessments of clinical competence. |
Q35601690 | Audit of compliance to adjuvant chemotherapy and radiotherapy guidelines in breast cancer in a cancer network |
Q30239832 | Axillary treatment for operable primary breast cancer. |
Q52838816 | Axillary treatment in women with one or two sentinel nodes with macrometastases: more evidence is needed to inform practice. |
Q51917785 | Breast cancer follow-up: could primary care be the right venue? |
Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
Q96132023 | Breast cancer surgery in older women: outcomes of the Bridging Age Gap in Breast Cancer study |
Q96825417 | Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancer |
Q102318444 | Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life |
Q42697893 | Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q37368484 | Case report: the ultrasound and Doppler appearances of pelvic varices |
Q51646130 | Characterisation of an experimental model of chronic lower limb ischaemia in the anaesthetised rat. |
Q51465348 | Common duct diameter as an independent predictor of choledocholithiasis: is it useful? |
Q43274554 | Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q49560395 | Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial. |
Q44302616 | Copper Deficiency Alters Vasodilation in the Rat Cremaster Muscle Microcirculation |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q38088366 | Current status and future prospects for anti-angiogenic therapies in cancer. |
Q84526802 | Cutaneous angiosarcoma after breast conserving treatment for bilateral breast cancers in a BRCA-1 gene mutation carrier--a case report and review of the literature |
Q33412299 | Description and reporting of surgical data--scope for improvement? |
Q36918154 | Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus |
Q50530596 | Does Changing Examiner Stations During UK Postgraduate Surgery Objective Structured Clinical Examinations Influence Examination Reliability and Candidates' Scores? |
Q77621329 | Drilling efficiency and temperature elevation of three types of Kirschner-wire point |
Q48264790 | Dyspraxia in clinical education: a review |
Q51383601 | Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo. |
Q33181821 | Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro. |
Q51667177 | Effects of sedation and supplemental oxygen during upper alimentary tract endoscopy. |
Q61449015 | Efficient development and usability testing of decision support interventions for older women with breast cancer |
Q33288626 | Endostatin gene variation and protein levels in breast cancer susceptibility and severity |
Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
Q38737950 | Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines. |
Q50973788 | Evaluation of fluorescent plasma markers for in vivo microscopy of the microcirculation. |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q35661406 | Fine-mapping CASP8 risk variants in breast cancer |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
Q50899464 | Healthcare professionals' preferences for surgery or primary endocrine therapy to treat older women with operable breast cancer. |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
Q28485381 | High quality genomic copy number data from archival formalin-fixed paraffin-embedded leiomyosarcoma: optimisation of universal linkage system labelling |
Q92771850 | Human factors in medicine: the art of common sense at work |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q67959467 | Importance of light dose in fluorescent microscopy |
Q47333386 | Information needs and decision-making preferences of older women offered a choice between surgery and primary endocrine therapy for early breast cancer |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q33250259 | Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. |
Q40460962 | Intestinal endometriosis: presentation, investigation, and surgical management. |
Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
Q37452183 | Is nitric oxide important in photodynamic therapy? |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q37999119 | Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). |
Q49485930 | Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review. |
Q47269753 | Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing |
Q51407477 | Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo. |
Q91335254 | Medical Students' Knowledge and Attitudes Toward Shared Decision Making: Results From a Multinational, Cross-Sectional Survey |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q39668509 | Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales. |
Q102073408 | National inter-rater agreement of standardised simulated-patient-based assessments |
Q46792535 | Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer |
Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q53082925 | Offering informed choice about breast screening. |
Q88780519 | Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival |
Q57299103 | Opportunities and priorities for breast surgical research |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q36873786 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q38202258 | Primary endocrine therapy as a treatment for older women with operable breast cancer - a comparison of randomised controlled trial and cohort study findings. |
Q67966189 | Prostanoid antagonists inhibit the response of the microcirculation to "early" photodynamic therapy |
Q35968721 | Publication of surgical abstracts in full text: a retrospective cohort study |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q50165876 | Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy. |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q24806157 | Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity |
Q35994724 | Short-term dietary copper deficiency does not inhibit angiogenesis in tumours implanted in striated muscle |
Q61804345 | Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study |
Q55003989 | Sister Chromatid Exchange and Genomic Instability in Soft Tissue Sarcomas: Potential Implications for Response to DNA-Damaging Treatments. |
Q33593016 | Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies |
Q96223495 | The Carbon Footprint of Surgical Operations: A Systematic Review |
Q36023363 | The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer |
Q100751136 | The care of older cancer patients in the United Kingdom |
Q42280945 | The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo |
Q42204434 | The effect of photodynamic therapy on the microcirculation |
Q34449139 | The history of photodetection and photodynamic therapy. |
Q67903315 | The influence of photodynamic therapy on the ultrastructure of the normal rat bladder |
Q69682976 | The rat urinary bladder: vasoactivity and macromolecular leakage in a new model |
Q41017408 | The relationship between semaphorin 3C and microvessel density in the progression of breast and oral neoplasia |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q35092939 | The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis |
Q37122001 | Tissue factor, angiogenesis and tumour progression |
Q37967810 | Transforming Growth Factor-β and Endoglin Signaling Orchestrate Wound Healing |
Q35658679 | Understanding older women's decision making and coping in the context of breast cancer treatment |
Q39061298 | Vascular-targeted agents for the treatment of angiosarcoma |
Q47977122 | What influences healthcare professionals' treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment. |
Search more.